Kimberly Stegmaier

Hematology | Oncology
450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications

Pediatric sarcomas: challenges and opportunities.

Pediatric sarcomas: challenges and opportunities.

Journal: Genes & development
Published: August 04, 2026

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Journal: Science translational medicine
Published: July 08, 2026

Evaluation of HDAC8 as a Druggable Target in STAG2-Mutant Ewing Sarcoma.

Evaluation of HDAC8 as a Druggable Target in STAG2-Mutant Ewing Sarcoma.

Journal: ACS chemical biology
Published: April 08, 2026

An epigenetic bifunctional that toggles between transactivation and repression.

An epigenetic bifunctional that toggles between transactivation and repression.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

Journal: bioRxiv : the preprint server for biology
Published: March 18, 2026

A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026

A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026

Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation.

Inhibition of USP7 Destabilizes the Noncanonical PRC1.1 Complex and Induces Neuroblastoma Differentiation.

Journal: Molecular cancer research : MCR
Published: October 22, 2025

SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications.

SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications.

Journal: NAR cancer
Published: October 11, 2025

USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

Journal: Blood
Published: September 29, 2025

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025

Chromatin Perturbation Promotes Susceptibility to Hypomethylating Agents.

Chromatin Perturbation Promotes Susceptibility to Hypomethylating Agents.

Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Showing 1-12 of 169

Last Updated: 09/26/2026